McKesson Debt to Equity Ratio 2012-2026 | MCK
Current and historical debt to equity ratio values for McKesson (MCK) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. McKesson debt/equity for the three months ending June 30, 2026 was 0.00.
| McKesson Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2026-06-30 | $92.19B | $-3.86B | -23.86 |
| 2026-03-31 | $84.10B | $-1.78B | -47.33 |
| 2025-12-31 | $85.09B | $-0.90B | -94.44 |
| 2025-09-30 | $85.52B | $-1.36B | -63.11 |
| 2025-06-30 | $82.90B | $-1.59B | -52.20 |
| 2025-03-31 | $76.83B | $-1.69B | -45.36 |
| 2024-12-31 | $73.79B | $-2.70B | -27.29 |
| 2024-09-30 | $75.07B | $-2.64B | -28.41 |
| 2024-06-30 | $73.05B | $-1.38B | -52.90 |
| 2024-03-31 | $69.04B | $-1.60B | -43.18 |
| 2023-12-31 | $68.19B | $-1.68B | -40.54 |
| 2023-09-30 | $67.56B | $-1.46B | -46.14 |
| 2023-06-30 | $65.34B | $-1.24B | -52.69 |
| 2023-03-31 | $63.81B | $-1.49B | -42.83 |
| 2022-12-31 | $64.78B | $-2.09B | -31.01 |
| 2022-09-30 | $64.33B | $-1.25B | -51.51 |
| 2022-06-30 | $63.77B | $-1.47B | -43.32 |
| 2022-03-31 | $65.09B | $-1.79B | -36.32 |
| 2021-12-31 | $64.50B | $-0.79B | -81.95 |
| 2021-09-30 | $63.69B | $-0.09B | -732.05 |
| 2021-06-30 | $62.94B | $-0.05B | -1398.64 |
| 2021-03-31 | $64.84B | $0.18B | 370.51 |
| 2020-12-31 | $62.12B | $-0.28B | -224.27 |
| 2020-09-30 | $55.47B | $6.09B | 9.11 |
| 2020-06-30 | $52.01B | $5.65B | 9.20 |
| 2020-03-31 | $55.94B | $5.31B | 10.54 |
| 2019-12-31 | $54.49B | $6.39B | 8.53 |
| 2019-09-30 | $52.30B | $6.69B | 7.82 |
| 2019-06-30 | $53.61B | $8.07B | 6.65 |
| 2019-03-31 | $51.39B | $8.29B | 6.20 |
| 2018-12-31 | $51.62B | $9.39B | 5.50 |
| 2018-09-30 | $51.89B | $9.53B | 5.44 |
| 2018-06-30 | $51.64B | $9.65B | 5.35 |
| 2018-03-31 | $50.32B | $10.06B | 5.00 |
| 2017-12-31 | $52.24B | $11.97B | 4.36 |
| 2017-09-30 | $52.48B | $11.36B | 4.62 |
| 2017-06-30 | $50.30B | $11.51B | 4.37 |
| 2017-03-31 | $49.70B | $11.27B | 4.41 |
| 2016-12-31 | $50.02B | $7.85B | 6.37 |
| 2016-09-30 | $48.69B | $9.62B | 5.06 |
| 2016-06-30 | $48.41B | $9.49B | 5.10 |
| 2016-03-31 | $47.52B | $9.01B | 5.28 |
| 2015-12-31 | $46.13B | $8.96B | 5.15 |
| 2015-09-30 | $46.95B | $8.87B | 5.29 |
| 2015-06-30 | $46.99B | $8.94B | 5.26 |
| 2015-03-31 | $45.79B | $8.09B | 5.66 |
| 2014-12-31 | $45.95B | $9.16B | 5.02 |
| 2014-09-30 | $41.71B | $10.53B | 3.96 |
| 2014-06-30 | $42.24B | $10.77B | 3.92 |
| 2014-03-31 | $41.44B | $10.32B | 4.02 |
| 2013-12-31 | $28.45B | $8.03B | 3.55 |
| 2013-09-30 | $27.96B | $7.99B | 3.50 |
| 2013-06-30 | $28.08B | $7.41B | 3.79 |
| 2013-03-31 | $27.72B | $7.07B | 3.92 |
| 2012-12-31 | $25.78B | $7.65B | 3.37 |
| 2012-09-30 | $25.25B | $7.72B | 3.27 |
| 2012-06-30 | $24.55B | $7.20B | 3.41 |
| 2012-03-31 | $26.26B | $6.83B | 3.85 |
| 2011-12-31 | $25.70B | $7.46B | 3.45 |
| 2011-09-30 | $24.79B | $7.12B | 3.48 |
| 2011-06-30 | $24.10B | $6.92B | 3.48 |
| 2011-03-31 | $23.67B | $7.22B | 3.28 |
| 2010-12-31 | $23.32B | $7.08B | 3.29 |
| 2010-09-30 | $19.98B | $6.82B | 2.93 |
| 2010-06-30 | $20.52B | $6.88B | 2.98 |
| 2010-03-31 | $20.66B | $7.53B | 2.74 |
| 2009-12-31 | $20.42B | $7.12B | 2.87 |
| 2009-09-30 | $19.91B | $6.72B | 2.96 |
| 2009-06-30 | $19.45B | $6.27B | 3.10 |
| 2009-03-31 | $19.07B | $6.19B | 3.08 |
| 2008-12-31 | $19.14B | $6.16B | 3.11 |
| 2008-09-30 | $18.23B | $6.35B | 2.87 |
| 2008-06-30 | $18.75B | $6.24B | 3.00 |
| 2008-03-31 | $18.48B | $6.12B | 3.02 |
| 2007-12-31 | $18.86B | $6.51B | 2.90 |
| 2007-09-30 | $18.65B | $6.38B | 2.92 |
| 2007-06-30 | $17.87B | $6.44B | 2.78 |
| 2007-03-31 | $17.67B | $6.27B | 2.82 |
| 2006-12-31 | $16.39B | $6.10B | 2.69 |
| 2006-09-30 | $15.56B | $5.92B | 2.63 |
| 2006-06-30 | $15.43B | $5.91B | 2.61 |
| 2006-03-31 | $15.05B | $5.91B | 2.55 |
| 2005-12-31 | $14.85B | $5.91B | 2.51 |
| 2005-09-30 | $14.60B | $5.85B | 2.50 |
| 2005-06-30 | $13.39B | $5.74B | 2.34 |
| 2005-03-31 | $13.50B | $5.28B | 2.56 |
| 2004-12-31 | $13.76B | $4.93B | 2.79 |
| 2004-09-30 | $12.43B | $5.53B | 2.25 |
| 2004-06-30 | $11.72B | $5.42B | 2.16 |
| 2004-03-31 | $11.08B | $5.17B | 2.14 |
| 2003-12-31 | $10.99B | $4.97B | 2.21 |
| 2003-09-30 | $10.53B | $4.85B | 2.17 |
| 2003-06-30 | $10.09B | $4.67B | 2.16 |
| 2003-03-31 | $9.84B | $4.53B | 2.17 |
| 2002-12-31 | $9.47B | $4.33B | 2.19 |
| 2002-09-30 | $9.67B | $4.20B | 2.30 |
| 2002-06-30 | $9.37B | $4.10B | 2.29 |
| 2002-03-31 | $9.39B | $3.94B | 2.38 |
| 2001-12-31 | $9.01B | $3.78B | 2.38 |
| 2001-09-30 | $8.51B | $3.68B | 2.31 |
| 2001-06-30 | $8.45B | $3.62B | 2.33 |
| 2001-03-31 | $8.04B | $3.49B | 2.30 |
| 2000-12-31 | $7.72B | $3.72B | 2.08 |
| 2000-09-30 | $6.88B | $3.67B | 1.88 |
| 2000-06-30 | $6.87B | $3.62B | 1.90 |
| 2000-03-31 | $6.81B | $3.57B | 1.91 |
| 1999-12-31 | $7.03B | $3.17B | 2.22 |
| 1999-09-30 | $6.49B | $3.01B | 2.15 |
| 1999-06-30 | $6.37B | $2.96B | 2.15 |
| 1999-03-31 | $6.20B | $2.88B | 2.15 |
| 1998-12-31 | $5.76B | $1.68B | 3.43 |
| 1998-09-30 | $5.39B | $1.63B | 3.30 |
| 1998-06-30 | $4.74B | $1.56B | 3.04 |
| 1998-03-31 | $4.20B | $1.41B | 2.99 |
| 1997-12-31 | $4.02B | $1.56B | 2.58 |
| 1997-09-30 | $3.71B | $1.53B | 2.43 |
| 1997-06-30 | $3.53B | $1.49B | 2.37 |
| 1997-03-31 | $3.72B | $1.46B | 2.55 |
| 1996-12-31 | $3.53B | $1.01B | 3.50 |
| 1996-09-30 | $2.59B | $0.98B | 2.64 |
| 1996-06-30 | $2.46B | $0.99B | 2.47 |
| 1996-03-31 | $2.30B | $1.07B | 2.16 |
| 1995-12-31 | $2.60B | $1.07B | 2.43 |
| 1995-09-30 | $2.53B | $1.05B | 2.40 |
| 1995-06-30 | $2.41B | $1.04B | 2.31 |
| 1995-03-31 | $2.47B | $1.01B | 2.43 |
| 1994-12-31 | $2.52B | $0.99B | 2.54 |
| 1994-09-30 | $2.29B | $0.71B | 3.21 |
| 1994-06-30 | $2.20B | $0.70B | 3.14 |
| 1994-03-31 | $0.31B | $0.68B | 0.46 |
| 1993-12-31 | $2.50B | $0.65B | 3.84 |
| 1993-09-30 | $2.36B | $0.63B | 3.77 |
| 1993-06-30 | $2.31B | $0.60B | 3.83 |
| 1993-03-31 | $2.18B | $0.62B | 3.52 |
| 1992-12-31 | $2.49B | $0.60B | 4.13 |
| 1992-09-30 | $2.29B | $0.58B | 3.91 |
| 1992-06-30 | $2.32B | $0.57B | 4.10 |
| 1992-03-31 | $2.20B | $0.56B | 3.97 |
| 1991-12-31 | $1.98B | $0.72B | 2.74 |
| 1991-09-30 | $2.00B | $0.70B | 2.84 |
| 1991-06-30 | $1.97B | $0.69B | 2.86 |
| 1991-03-31 | $1.77B | $0.68B | 2.62 |
| 1990-12-31 | $1.74B | $0.67B | 2.60 |
| 1990-09-30 | $1.74B | $0.65B | 2.66 |
| 1990-06-30 | $1.60B | $0.65B | 2.46 |
| 1990-03-31 | $1.64B | $0.68B | 2.40 |
| 1989-12-31 | $1.69B | $0.70B | 2.42 |
| 1989-09-30 | $1.63B | $0.70B | 2.34 |
| 1989-06-30 | $1.58B | $0.70B | 2.27 |
| 1989-03-31 | $1.40B | $0.69B | 2.03 |
| 1988-12-31 | $1.57B | $0.70B | 2.24 |
| 1988-09-30 | $1.48B | $0.72B | 2.05 |
| 1988-06-30 | $1.45B | $0.71B | 2.04 |
| 1988-03-31 | $1.53B | $0.70B | 2.18 |
| 1987-12-31 | $1.59B | $0.69B | 2.32 |
| 1987-09-30 | $1.44B | $0.72B | 2.01 |
| 1987-06-30 | $1.47B | $0.73B | 2.02 |
| 1987-03-31 | $1.43B | $0.76B | 1.88 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $104.880B | $403.430B |
| McKesson Corporation distributes pharmaceuticals, medical-surgical supplies and health and beauty care products principally in North America. The Company also develops, implements and supports software which facilitates the integration of data throughout the health enterprise. McKesson Corporation is based in IRVING, Texas. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardinal Health (CAH) | United States | $54.109B | 20.66 |
| Becton Dickinson (BDX) | United States | $51.228B | 14.30 |
| West Pharmaceutical Services (WST) | United States | $25.687B | 42.94 |
| Straumann Holding AG (SAUHY) | Switzerland | $18.592B | 0.00 |
| Align Technology (ALGN) | United States | $10.528B | 16.28 |
| Cooper (COO) | United States | $10.130B | 11.56 |
| Henry Schein (HSIC) | United States | $9.754B | 16.48 |
| Merit Medical Systems (MMSI) | United States | $5.146B | 23.48 |
| DENTSPLY SIRONA (XRAY) | United States | $1.960B | 6.87 |
| CONMED (CNMD) | United States | $1.406B | 9.82 |
| STAAR Surgical (STAA) | United States | $1.125B | 35.07 |
| Pro-Dex (PDEX) | United States | $0.214B | 19.97 |
| Lifevantage (LFVN) | United States | $0.077B | 11.04 |